Скачать или смотреть Challenges in clinical use of CSF-based liquid biopsies for brain tumors

Stephen Bagley, MD, MSCE, University of Pennsylvania, Philadelphia, PA, provides an overview of the challenges in using cerebrospinal fluid (CSF) as a minimally invasive method for diagnosing and monitoring brain tumors. While CSF collection is less invasive than acquiring brain tissue, it still poses several barriers, including institutional comfort levels, ease of access, and the need to prove clinical utility. However, there are select clinical scenarios where spinal fluid analysis can already provide valuable information, such as in cases of difficult-to-sample brain masses. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.